vs
Side-by-side financial comparison of Organon & Co. (OGN) and PRICESMART INC (PSMT). Click either name above to swap in a different company.
Organon & Co. is the larger business by last-quarter revenue ($1.5B vs $1.4B, roughly 1.1× PRICESMART INC). PRICESMART INC runs the higher net margin — 2.9% vs -13.6%, a 16.5% gap on every dollar of revenue. On growth, PRICESMART INC posted the faster year-over-year revenue change (9.9% vs -5.3%). Organon & Co. produced more free cash flow last quarter ($96.0M vs $32.6M). Over the past eight quarters, PRICESMART INC's revenue compounded faster (3.5% CAGR vs -3.6%).
Organon & Co. is an American pharmaceutical company headquartered in Jersey City, New Jersey. Organon specializes in the following core therapeutic fields: reproductive medicine, contraception, psychiatry, hormone replacement therapy (HRT), and anesthesia. Organon produces all its products outside of the United States but receives a third of its revenue from the United States.
PRICESMART INCPSMTEarnings & Financial Report
PriceSmart, Inc. is a United States based operator of membership warehouse clubs in Central America, the Caribbean, and South America. PriceSmart was founded by Sol and Robert Price, founders of Price Club; Robert Price is chairman of the board.
OGN vs PSMT — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $1.5B | $1.4B |
| Net Profit | $-205.0M | $40.2M |
| Gross Margin | 49.2% | 17.7% |
| Operating Margin | -9.8% | 4.6% |
| Net Margin | -13.6% | 2.9% |
| Revenue YoY | -5.3% | 9.9% |
| Net Profit YoY | -288.1% | 7.3% |
| EPS (diluted) | $-0.78 | $1.29 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.5B | $1.4B | ||
| Q3 25 | $1.6B | $1.3B | ||
| Q2 25 | $1.6B | $1.3B | ||
| Q1 25 | $1.5B | $1.4B | ||
| Q4 24 | $1.6B | $1.3B | ||
| Q3 24 | $1.6B | $1.2B | ||
| Q2 24 | $1.6B | $1.2B | ||
| Q1 24 | $1.6B | $1.3B |
| Q4 25 | $-205.0M | $40.2M | ||
| Q3 25 | $160.0M | $31.5M | ||
| Q2 25 | $145.0M | $35.2M | ||
| Q1 25 | $87.0M | $43.8M | ||
| Q4 24 | $109.0M | $37.4M | ||
| Q3 24 | $359.0M | $29.1M | ||
| Q2 24 | $195.0M | $32.5M | ||
| Q1 24 | $201.0M | $39.3M |
| Q4 25 | 49.2% | 17.7% | ||
| Q3 25 | 53.5% | — | ||
| Q2 25 | 54.8% | — | ||
| Q1 25 | 55.6% | 17.1% | ||
| Q4 24 | 56.3% | 17.4% | ||
| Q3 24 | 58.3% | — | ||
| Q2 24 | 58.4% | — | ||
| Q1 24 | 59.0% | — |
| Q4 25 | -9.8% | 4.6% | ||
| Q3 25 | 15.2% | 4.0% | ||
| Q2 25 | 14.4% | 4.3% | ||
| Q1 25 | 6.7% | 4.8% | ||
| Q4 24 | 8.1% | 4.6% | ||
| Q3 24 | 13.1% | 4.0% | ||
| Q2 24 | 14.6% | 4.1% | ||
| Q1 24 | 14.5% | 4.9% |
| Q4 25 | -13.6% | 2.9% | ||
| Q3 25 | 10.0% | 2.4% | ||
| Q2 25 | 9.1% | 2.7% | ||
| Q1 25 | 5.8% | 3.2% | ||
| Q4 24 | 6.8% | 3.0% | ||
| Q3 24 | 22.7% | 2.4% | ||
| Q2 24 | 12.1% | 2.6% | ||
| Q1 24 | 12.4% | 3.0% |
| Q4 25 | $-0.78 | $1.29 | ||
| Q3 25 | $0.61 | $1.02 | ||
| Q2 25 | $0.56 | $1.14 | ||
| Q1 25 | $0.33 | $1.45 | ||
| Q4 24 | $0.42 | $1.21 | ||
| Q3 24 | $1.38 | $0.94 | ||
| Q2 24 | $0.75 | $1.08 | ||
| Q1 24 | $0.78 | $1.31 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $574.0M | $320.6M |
| Total DebtLower is stronger | $8.6B | $180.3M |
| Stockholders' EquityBook value | $752.0M | $1.3B |
| Total Assets | $12.9B | $2.4B |
| Debt / EquityLower = less leverage | 11.49× | 0.14× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $574.0M | $320.6M | ||
| Q3 25 | $672.0M | $314.2M | ||
| Q2 25 | $599.0M | $262.4M | ||
| Q1 25 | $547.0M | $247.3M | ||
| Q4 24 | $675.0M | $222.2M | ||
| Q3 24 | $763.0M | $225.5M | ||
| Q2 24 | $704.0M | $228.2M | ||
| Q1 24 | $575.0M | $264.2M |
| Q4 25 | $8.6B | $180.3M | ||
| Q3 25 | $8.8B | $186.6M | ||
| Q2 25 | $8.9B | $103.1M | ||
| Q1 25 | $9.0B | $107.1M | ||
| Q4 24 | $8.9B | $115.6M | ||
| Q3 24 | $8.7B | $130.4M | ||
| Q2 24 | $8.7B | $135.1M | ||
| Q1 24 | $8.7B | $140.0M |
| Q4 25 | $752.0M | $1.3B | ||
| Q3 25 | $906.0M | $1.2B | ||
| Q2 25 | $733.0M | $1.2B | ||
| Q1 25 | $542.0M | $1.2B | ||
| Q4 24 | $472.0M | $1.2B | ||
| Q3 24 | $493.0M | $1.1B | ||
| Q2 24 | $144.0M | $1.1B | ||
| Q1 24 | $48.0M | $1.1B |
| Q4 25 | $12.9B | $2.4B | ||
| Q3 25 | $13.6B | $2.3B | ||
| Q2 25 | $13.5B | $2.1B | ||
| Q1 25 | $13.2B | $2.1B | ||
| Q4 24 | $13.1B | $2.1B | ||
| Q3 24 | $12.8B | $2.0B | ||
| Q2 24 | $12.2B | $2.0B | ||
| Q1 24 | $11.9B | $2.0B |
| Q4 25 | 11.49× | 0.14× | ||
| Q3 25 | 9.74× | 0.15× | ||
| Q2 25 | 12.14× | 0.08× | ||
| Q1 25 | 16.52× | 0.09× | ||
| Q4 24 | 18.81× | 0.10× | ||
| Q3 24 | 17.75× | 0.12× | ||
| Q2 24 | 60.11× | 0.12× | ||
| Q1 24 | 181.54× | 0.13× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $141.0M | $71.2M |
| Free Cash FlowOCF − Capex | $96.0M | $32.6M |
| FCF MarginFCF / Revenue | 6.4% | 2.4% |
| Capex IntensityCapex / Revenue | 3.0% | 2.8% |
| Cash ConversionOCF / Net Profit | — | 1.77× |
| TTM Free Cash FlowTrailing 4 quarters | $538.0M | $125.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $141.0M | $71.2M | ||
| Q3 25 | $264.0M | $82.1M | ||
| Q2 25 | $220.0M | $52.8M | ||
| Q1 25 | $75.0M | $87.9M | ||
| Q4 24 | $390.0M | $38.5M | ||
| Q3 24 | $141.0M | $41.8M | ||
| Q2 24 | $332.0M | $38.1M | ||
| Q1 24 | $76.0M | $86.6M |
| Q4 25 | $96.0M | $32.6M | ||
| Q3 25 | $218.0M | $25.6M | ||
| Q2 25 | $181.0M | $14.0M | ||
| Q1 25 | $43.0M | $53.2M | ||
| Q4 24 | $335.0M | $10.3M | ||
| Q3 24 | $99.0M | $15.2M | ||
| Q2 24 | $300.0M | $-308.0K | ||
| Q1 24 | $30.0M | $16.4M |
| Q4 25 | 6.4% | 2.4% | ||
| Q3 25 | 13.6% | 1.9% | ||
| Q2 25 | 11.4% | 1.1% | ||
| Q1 25 | 2.8% | 3.9% | ||
| Q4 24 | 21.0% | 0.8% | ||
| Q3 24 | 6.3% | 1.2% | ||
| Q2 24 | 18.7% | -0.0% | ||
| Q1 24 | 1.8% | 1.3% |
| Q4 25 | 3.0% | 2.8% | ||
| Q3 25 | 2.9% | 4.2% | ||
| Q2 25 | 2.4% | 2.9% | ||
| Q1 25 | 2.1% | 2.5% | ||
| Q4 24 | 3.5% | 2.2% | ||
| Q3 24 | 2.7% | 2.2% | ||
| Q2 24 | 2.0% | 3.1% | ||
| Q1 24 | 2.8% | 5.4% |
| Q4 25 | — | 1.77× | ||
| Q3 25 | 1.65× | 2.60× | ||
| Q2 25 | 1.52× | 1.50× | ||
| Q1 25 | 0.86× | 2.01× | ||
| Q4 24 | 3.58× | 1.03× | ||
| Q3 24 | 0.39× | 1.44× | ||
| Q2 24 | 1.70× | 1.17× | ||
| Q1 24 | 0.38× | 2.20× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
OGN
Segment breakdown not available.
PSMT
| Fresh Foods | $454.9M | 33% |
| Caribbean Operations Segment | $396.5M | 29% |
| Colombia Operations Segment | $204.1M | 15% |
| Hardlines | $162.6M | 12% |
| Softlines | $99.8M | 7% |
| ship Income Member | $24.5M | 2% |
| Health Services | $14.5M | 1% |
| Other Revenue And Income | $4.2M | 0% |
| United States Operations Segment | $510.0K | 0% |
| Export Sales | $359.0K | 0% |
